chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction, Vaccination site swelling
Clinical narrative: Swelling at site of injection; Hardness at site of injection; Redness at site of injection; Severe itching at site of injection; Headache; Bilateral arm muscle pain; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), MYALGIA (Bilateral arm muscle pain), FATIGUE (Fatigue), VACCINATION SITE SWELLING (Swelling at site of injection) and VACCINATION SITE REACTION (Hardness at site of injection) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high and Hyperlipidemia.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced HEADACHE (Headache), MYALGIA (Bilateral arm muscle pain) and FATIGUE (Fatigue). On 27-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Swelling at site of injection), VACCINATION SITE REACTION (Hardness at site of injection), INJECTION SITE ERYTHEMA (Redness at site of injection) and VACCINATION SITE PRURITUS (Severe itching at site of injection). At the time of the report, HEADACHE (Headache), MYALGIA (Bilateral arm muscle pain), FATIGUE (Fatigue), VACCINATION SITE SWELLING (Swelling at site of injection), VACCINATION SITE REACTION (Hardness at site of injection), INJECTION SITE ERYTHEMA (Redness at site of injection) and VACCINATION SITE PRURITUS (Severe itching at site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant Medications includes High Blood Pressure Medication ,Antihyperlipidemic Medication. Treatment Medications were not provided by the reporter.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dysgeusia, Fatigue, Hypoaesthesia oral, Myalgia
Clinical narrative: the tip of her tongue was tingling; no appetite; nauseous; mouth had a bad taste; mouth feel a little numb; soreness in her arm; achy feeling in her body; tiredness; Soreness in her arm; lips were tingling a little bit; funny taste in her mouth; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (lips were tingling a little bit), DYSGEUSIA (funny taste in her mouth), MYALGIA (soreness in her arm), MYALGIA (achy feeling in her body) and FATIGUE (tiredness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A121A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METOPROLOL TARTRATE and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PARAESTHESIA ORAL (lips were tingling a little bit) and DYSGEUSIA (funny taste in her mouth). On 28-Feb-2021, the patient experienced MYALGIA (soreness in her arm), MYALGIA (achy feeling in her body), FATIGUE (tiredness) and VACCINATION SITE PAIN (Soreness in her arm). On 01-Mar-2021, the patient experienced DYSGEUSIA (mouth had a bad taste) and HYPOAESTHESIA ORAL (mouth feel a little numb). On 03-Mar-2021, the patient experienced NAUSEA (nauseous). On 06-Mar-2021, the patient experienced DECREASED APPETITE (no appetite). On 07-Mar-2021, the patient experienced PARAESTHESIA ORAL (the tip of her tongue was tingling). On 27-Feb-2021, PARAESTHESIA ORAL (lips were tingling a little bit) had resolved. On 01-Mar-2021, MYALGIA (soreness in her arm), MYALGIA (achy feeling in her body), FATIGUE (tiredness) and VACCINATION SITE PAIN (Soreness in her arm) had resolved. On 05-Mar-2021, HYPOAESTHESIA ORAL (mouth feel a little numb) had resolved. On 07-Mar-2021, NAUSEA (nauseous) and DECREASED APPETITE (no appetite) had resolved. On 08-Mar-2021, PARAESTHESIA ORAL (the tip of her tongue was tingling) had resolved. At the time of the report, DYSGEUSIA (funny taste in her mouth) and DYSGEUSIA (mouth had a bad taste) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Medications were not provided by the reporter.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Paraesthesia oral, Vaccination site pain
Clinical narrative: the tip of her tongue was tingling; no appetite; nauseous; mouth had a bad taste; mouth feel a little numb; soreness in her arm; achy feeling in her body; tiredness; Soreness in her arm; lips were tingling a little bit; funny taste in her mouth; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (lips were tingling a little bit), DYSGEUSIA (funny taste in her mouth), MYALGIA (soreness in her arm), MYALGIA (achy feeling in her body) and FATIGUE (tiredness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A121A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METOPROLOL TARTRATE and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PARAESTHESIA ORAL (lips were tingling a little bit) and DYSGEUSIA (funny taste in her mouth). On 28-Feb-2021, the patient experienced MYALGIA (soreness in her arm), MYALGIA (achy feeling in her body), FATIGUE (tiredness) and VACCINATION SITE PAIN (Soreness in her arm). On 01-Mar-2021, the patient experienced DYSGEUSIA (mouth had a bad taste) and HYPOAESTHESIA ORAL (mouth feel a little numb). On 03-Mar-2021, the patient experienced NAUSEA (nauseous). On 06-Mar-2021, the patient experienced DECREASED APPETITE (no appetite). On 07-Mar-2021, the patient experienced PARAESTHESIA ORAL (the tip of her tongue was tingling). On 27-Feb-2021, PARAESTHESIA ORAL (lips were tingling a little bit) had resolved. On 01-Mar-2021, MYALGIA (soreness in her arm), MYALGIA (achy feeling in her body), FATIGUE (tiredness) and VACCINATION SITE PAIN (Soreness in her arm) had resolved. On 05-Mar-2021, HYPOAESTHESIA ORAL (mouth feel a little numb) had resolved. On 07-Mar-2021, NAUSEA (nauseous) and DECREASED APPETITE (no appetite) had resolved. On 08-Mar-2021, PARAESTHESIA ORAL (the tip of her tongue was tingling) had resolved. At the time of the report, DYSGEUSIA (funny taste in her mouth) and DYSGEUSIA (mouth had a bad taste) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Medications were not provided by the reporter.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Disorientation, Fatigue, Headache
Clinical narrative: Chills (felt a lot colder); Headache; Reaction was slower fatigue / fatigue past a week after getting; Disorientation; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Mar-2021. The most recent information was received on 17-Jul-2021 and was forwarded to Moderna on 17-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DISORIENTATION (Disorientation), CHILLS (Chills (felt a lot colder)), HEADACHE (Headache) and FATIGUE (Reaction was slower fatigue / fatigue past a week after getting) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 023M21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma since 26-Jul-1998, Allergy to animal (Allergy to cats), Pollen allergy, Grass allergy and Dust allergy. Concomitant products included MULTIVITAMIN GUMMY BEARS from 20-May-2020 to an unknown date for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced DISORIENTATION (Disorientation). On 03-Mar-2021, the patient experienced CHILLS (Chills (felt a lot colder)), HEADACHE (Headache) and FATIGUE (Reaction was slower fatigue / fatigue past a week after getting). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ALKA SELTZER [ACETYLSALICYLIC ACID]) at an unspecified dose and frequency. On 07-Mar-2021, HEADACHE (Headache) had resolved. On 20-Mar-2021, FATIGUE (Reaction was slower fatigue / fatigue past a week after getting) had resolved. At the time of the report, DISORIENTATION (Disorientation) had not resolved and CHILLS (Chills (felt a lot colder)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-257958 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Added medical history and concomitant medication. On 17-Jul-2021: The start date and stop date of the event (Fatigue) was changed.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Swollen tongue
Clinical narrative: puffiness on the back of tongue near the throat; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (puffiness on the back of tongue near the throat) and NAUSEA (nauseous) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced SWOLLEN TONGUE (puffiness on the back of tongue near the throat) and NAUSEA (nauseous). At the time of the report, SWOLLEN TONGUE (puffiness on the back of tongue near the throat) and NAUSEA (nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant Medications were  provided by Reporter No Treatment Medications were  provided by Reporter
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Joint swelling
Clinical narrative: Golf-sized swelling (lump) on left elbow; fatigue; headache; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Golf-sized swelling (lump) on left elbow), FATIGUE (fatigue), HEADACHE (headache) and ARTHRALGIA (joint pain) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's medical history was not reported.  Concurrent medical conditions included Type 1 diabetes mellitus. Concomitant products included RISPERIDONE and DULOXETINE for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced JOINT SWELLING (Golf-sized swelling (lump) on left elbow), FATIGUE (fatigue), HEADACHE (headache) and ARTHRALGIA (joint pain). The patient was treated with IBUPROFEN (ADVIL MIGRAINE) at a dose of UNK dosage form (2 pills). At the time of the report, JOINT SWELLING (Golf-sized swelling (lump) on left elbow), FATIGUE (fatigue), HEADACHE (headache) and ARTHRALGIA (joint pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included cholesterol medications. The patient self-medicated with Advil migraine (2 pills) and made the symptoms worse due to too much chemicals. The patient was scheduled for second dose on 30-Mar-2021. It was reported that everything was fine.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Follow up received on 05-MAY-2021 in which event outcome updated On 13-Jul-2021: Non-Significant Follow Up Appended
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Vaccination site pain
Clinical narrative: foggy head; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (foggy head) and VACCINATION SITE PAIN (pain at the injection site) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 040A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included VITAMIN B [VITAMIN B NOS] for an unknown indication.   On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain at the injection site). On 08-Mar-2021, the patient experienced FEELING ABNORMAL (foggy head). On 08-Mar-2021, FEELING ABNORMAL (foggy head) had resolved. At the time of the report, VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.            Concomitant medications was not reported.  Treatment for the events was not provided Consent given.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Bone pain, Feeling hot, Pain, Pyrexia
Clinical narrative: sore; his bones were sore; felt warm; temperature of almost 101°F; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (felt warm), PYREXIA (temperature of almost 101°F), PAIN (sore) and BONE PAIN (his bones were sore) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included Blood pressure. Concomitant products included PANTOPRAZOLE SODIUM for Blood pressure, SIMVASTATIN, MULTIVITAMINS & MINERALS PLUS LUTEIN and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced FEELING HOT (felt warm) and PYREXIA (temperature of almost 101°F). On 28-Feb-2021, the patient experienced PAIN (sore) and BONE PAIN (his bones were sore). On 28-Feb-2021, FEELING HOT (felt warm), PYREXIA (temperature of almost 101°F), PAIN (sore) and BONE PAIN (his bones were sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Migraine, Myalgia, Nausea
Clinical narrative: excruciating migraine; nausea; throwing up all day; muscle ache; joint pain; chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MIGRAINE (excruciating migraine), NAUSEA (nausea), VOMITING (throwing up all day), MYALGIA (muscle ache) and ARTHRALGIA (joint pain) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced NAUSEA (nausea), VOMITING (throwing up all day), MYALGIA (muscle ache), ARTHRALGIA (joint pain) and CHILLS (chills). On 11-Mar-2021, the patient experienced MIGRAINE (excruciating migraine). At the time of the report, MIGRAINE (excruciating migraine), NAUSEA (nausea), VOMITING (throwing up all day), MYALGIA (muscle ache), ARTHRALGIA (joint pain) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided Treatment information provided as Toroidal and fluids.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vomiting
Clinical narrative: excruciating migraine; nausea; throwing up all day; muscle ache; joint pain; chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MIGRAINE (excruciating migraine), NAUSEA (nausea), VOMITING (throwing up all day), MYALGIA (muscle ache) and ARTHRALGIA (joint pain) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced NAUSEA (nausea), VOMITING (throwing up all day), MYALGIA (muscle ache), ARTHRALGIA (joint pain) and CHILLS (chills). On 11-Mar-2021, the patient experienced MIGRAINE (excruciating migraine). At the time of the report, MIGRAINE (excruciating migraine), NAUSEA (nausea), VOMITING (throwing up all day), MYALGIA (muscle ache), ARTHRALGIA (joint pain) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided Treatment information provided as Toroidal and fluids.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea
Clinical narrative: Headache; Fatigue; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), FATIGUE (Fatigue) and NAUSEA (Nausea) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced HEADACHE (Headache), FATIGUE (Fatigue) and NAUSEA (Nausea). At the time of the report, HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.  Treatment information was not reported.
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Red spot which is size of half a dollar and painful and sore to touch; Red spot which is size of half a dollar and painful and sore to touch; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Red spot which is size of half a dollar and painful and sore to touch) and INJECTION SITE PAIN (Red spot which is size of half a dollar and painful and sore to touch) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced INJECTION SITE ERYTHEMA (Red spot which is size of half a dollar and painful and sore to touch). On an unknown date, the patient experienced INJECTION SITE PAIN (Red spot which is size of half a dollar and painful and sore to touch). At the time of the report, INJECTION SITE ERYTHEMA (Red spot which is size of half a dollar and painful and sore to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Sensitive skin, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Increased sensitivity; Itching in the area of injection; Circular raised left arm rash; Red oval spot around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of SENSITIVE SKIN (Increased sensitivity), VACCINATION SITE PRURITUS (Itching in the area of injection), VACCINATION SITE RASH (Circular raised left arm rash) and VACCINATION SITE ERYTHEMA (Red oval spot around the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergic to codine), Raynauds since 1997, Systemic lupus erythematosus since 1988, Supraventricular tachycardia since 2013 and Fibromyalgia since 1988. Concomitant products included LOSARTAN, DILTIAZEM, HYDROXYCHLOROQUINE SULFATE (PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]), OMEPRAZOLE, TIMOLOL MALEATE and CICLOSPORIN (RESTASIS) for an unknown indication.    On 05-Mar-2021 at 6:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red oval spot around the injection site). On 10-Mar-2021 at 6:00 AM, the patient experienced VACCINATION SITE RASH (Circular raised left arm rash). On an unknown date, the patient experienced SENSITIVE SKIN (Increased sensitivity) and VACCINATION SITE PRURITUS (Itching in the area of injection). On 25-Mar-2021, VACCINATION SITE RASH (Circular raised left arm rash) and VACCINATION SITE ERYTHEMA (Red oval spot around the injection site) had resolved. At the time of the report, SENSITIVE SKIN (Increased sensitivity) was resolving and VACCINATION SITE PRURITUS (Itching in the area of injection) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that on 16-Mar-2021 the patient got little better from Sensitivity. Treatment information reported included topical antibiotic cream over the counter.  Approximately five days after injection in left arm, an area below the injection begin itching and patient noticed a small size red spot. The itch continued with increased raised area spreading with an oval shape.  The rash and itch lasted for more than 7 days. Patient applied atopical itch cream which helped with the itch. It was approximately 10 days or more that the rash/raised area begin to subside. At time of this report, there was no further rashes or itching in the area.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow up received on 14-Jul-2021, history. Patient demographics, allergies, dose 2 details, concomitant medication, added an additional event. Updated event outcome for the Vaccination site pruritus.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Body aches/muscle pain; Headaches; Joint pain; Chills; Fever; Fatigue and tiredness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches/muscle pain), HEADACHE (Headaches), ARTHRALGIA (Joint pain), CHILLS (Chills) and PYREXIA (Fever) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Atopic dermatitis. Concomitant products included LOSARTAN and NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced MYALGIA (Body aches/muscle pain), HEADACHE (Headaches), ARTHRALGIA (Joint pain), CHILLS (Chills), PYREXIA (Fever) and FATIGUE (Fatigue and tiredness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MYALGIA (Body aches/muscle pain), HEADACHE (Headaches), ARTHRALGIA (Joint pain), CHILLS (Chills), PYREXIA (Fever) and FATIGUE (Fatigue and tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Body aches/muscle pain; Headaches; Joint pain; Chills; Fever; Fatigue and tiredness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches/muscle pain), HEADACHE (Headaches), ARTHRALGIA (Joint pain), CHILLS (Chills) and PYREXIA (Fever) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Atopic dermatitis. Concomitant products included LOSARTAN and NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced MYALGIA (Body aches/muscle pain), HEADACHE (Headaches), ARTHRALGIA (Joint pain), CHILLS (Chills), PYREXIA (Fever) and FATIGUE (Fatigue and tiredness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MYALGIA (Body aches/muscle pain), HEADACHE (Headaches), ARTHRALGIA (Joint pain), CHILLS (Chills), PYREXIA (Fever) and FATIGUE (Fatigue and tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Immune-mediated adverse reaction, Urticaria, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: autoimmune reaction; upper arm being very itchy/sore and felt some lumps as the day progressed, she developed more; upper arm being very itchy/sore and felt some lumps as the day progressed, she developed more; very hot and "hivey", bright red; very hot and "hivey", bright red; This spontaneous case was reported by a  and describes the occurrence of IMMUNE-MEDIATED ADVERSE REACTION (autoimmune reaction), VACCINATION SITE PRURITUS (upper arm being very itchy/sore and felt some lumps as the day progressed, she developed more), VACCINATION SITE MASS (upper arm being very itchy/sore and felt some lumps as the day progressed, she developed more) and URTICARIA (very hot and "hivey", bright red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced IMMUNE-MEDIATED ADVERSE REACTION (autoimmune reaction), VACCINATION SITE PRURITUS (upper arm being very itchy/sore and felt some lumps as the day progressed, she developed more), VACCINATION SITE MASS (upper arm being very itchy/sore and felt some lumps as the day progressed, she developed more) and URTICARIA (very hot and "hivey", bright red).            Reporter did not allow further contact
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Contusion, Ecchymosis
Clinical narrative: bruises on my right arm and leg; ecchymosis; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CONTUSION (bruises on my right arm and leg) and ECCHYMOSIS (ecchymosis) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 644a21a and 032b21a) for COVID-19 vaccination.     The patient's past medical history included Emphysema since an unknown date and Hypertension since an unknown date. Concurrent medical conditions included Penicillin allergy, Drug allergy (lisinopril, metoprolol, channix, atorvastatin, menthol, phenytoin, propoxyphene n, acetaminophen), Contrast media allergy (allergic to iodinated contrast media) and Allergy to antibiotic (sulfa, penicillin, sulfasalazine, umeclidinium-vilanterol (inhaled fixed dose combination)). Concomitant products included LOSARTAN POTASSIUM for Hypertension, ROSUVASTATIN CALCIUM, EZETIMIBE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (ANORO), AMLODIPINE, ACETYLSALICYLIC ACID (ASPIRIN 81), CLOPIDOGREL and FINASTERIDE for an unknown indication.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced CONTUSION (bruises on my right arm and leg) and ECCHYMOSIS (ecchymosis). On 29-Mar-2021, CONTUSION (bruises on my right arm and leg) had resolved. At the time of the report, ECCHYMOSIS (ecchymosis) outcome was unknown.            Treatment for the events, included clopidogrel  On 12MAR2021, after the patient received the vaccination, he later developed bruises on his right arm and leg. He describes one of the bruises to be 4 inches long. He was seen at the emergency room and was diagnosed with Ecchymosis. Treatment was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Follow-up received on 15 Apr 2021 included no new information On 18-Apr-2021: No specific follow-up information recorded. On 18-Apr-2021: Follow up information received on 18-APR-2021, included Patient demographics, past medical history, allergies, Concomitant medications were updated. Second dose details are provided. Outcome of the event, bruising was recovered on 29 march 2021 (from unknown to recovered).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: Covid Arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid Arm) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20-2A and 011M20A) for COVID-19 vaccination.     Medical history was not reported.  Concomitant products included ROSUVASTATIN, METOPROLOL, ASPIRIN [ACETYLSALICYLIC ACID], MIRTAZAPINE and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE REACTION (Covid Arm). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency. On 10-Feb-2021, VACCINATION SITE REACTION (Covid Arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Fatigue, Heart rate, Insomnia, Myalgia
Clinical narrative: Anxious; Not sleeping well; Feels off; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxious), INSOMNIA (Not sleeping well), MYALGIA (Sore arm) and FATIGUE (Feels off) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Patient medication history was not provided by the reporter.     On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced MYALGIA (Sore arm). On an unknown date, the patient experienced ANXIETY (Anxious), INSOMNIA (Not sleeping well) and FATIGUE (Feels off). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Inflammation, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) for Sore arm, at an unspecified dose and frequency. On 15-Mar-2021, MYALGIA (Sore arm) had resolved. At the time of the report, ANXIETY (Anxious), INSOMNIA (Not sleeping well) and FATIGUE (Feels off) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: heart beats per minute (High) Elevated heart rate, 150 heart beats per minute (High) Heart rate of 150, heart beats per minute (High) High resting heart rate, heart beats per minute (abnormal) Fluctuations in heart rate and heart beats per minute (abnormal) Irregular heart beat.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Eating disorder, Headache, Inappropriate schedule of product administration, Pyrexia
Clinical narrative: Does not feel like eating; Duration between 2 doses more than 37 days; High Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of EATING DISORDER (Does not feel like eating), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Duration between 2 doses more than 37 days), PYREXIA (High Fever) and HEADACHE (Headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 011A2A4) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Allergy.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EATING DISORDER (Does not feel like eating), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Duration between 2 doses more than 37 days), PYREXIA (High Fever) and HEADACHE (Headache). At the time of the report, EATING DISORDER (Does not feel like eating), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Duration between 2 doses more than 37 days), PYREXIA (High Fever) and HEADACHE (Headache) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication included paracetamol
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fatigue, Nausea, Urinary tract infection
Clinical narrative: Developing a UTI; feeling tired and weakened; woozy and queasy; woozy and queasy; feeling tired and weakened; injection site muscular soreness for about a day and half; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (Developing a UTI), ASTHENIA (feeling tired and weakened), DIZZINESS (woozy and queasy), VACCINATION SITE PAIN (injection site muscular soreness for about a day and half) and NAUSEA (woozy and queasy) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced VACCINATION SITE PAIN (injection site muscular soreness for about a day and half). On an unknown date, the patient experienced URINARY TRACT INFECTION (Developing a UTI), ASTHENIA (feeling tired and weakened), DIZZINESS (woozy and queasy), NAUSEA (woozy and queasy) and FATIGUE (feeling tired and weakened). The patient was treated with CLARITHROMYCIN (MACROBID [CLARITHROMYCIN]) ongoing since an unknown date for UTI, at a dose of UNK FOR 7 DAYS and Manual therapy (she used ice to help relieve the sore arm) for Vaccination site pain. On 26-Feb-2021, VACCINATION SITE PAIN (injection site muscular soreness for about a day and half) had resolved. At the time of the report, URINARY TRACT INFECTION (Developing a UTI), ASTHENIA (feeling tired and weakened), DIZZINESS (woozy and queasy), NAUSEA (woozy and queasy) and FATIGUE (feeling tired and weakened) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Developing a UTI; feeling tired and weakened; woozy and queasy; woozy and queasy; feeling tired and weakened; injection site muscular soreness for about a day and half; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (Developing a UTI), ASTHENIA (feeling tired and weakened), DIZZINESS (woozy and queasy), VACCINATION SITE PAIN (injection site muscular soreness for about a day and half) and NAUSEA (woozy and queasy) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced VACCINATION SITE PAIN (injection site muscular soreness for about a day and half). On an unknown date, the patient experienced URINARY TRACT INFECTION (Developing a UTI), ASTHENIA (feeling tired and weakened), DIZZINESS (woozy and queasy), NAUSEA (woozy and queasy) and FATIGUE (feeling tired and weakened). The patient was treated with CLARITHROMYCIN (MACROBID [CLARITHROMYCIN]) ongoing since an unknown date for UTI, at a dose of UNK FOR 7 DAYS and Manual therapy (she used ice to help relieve the sore arm) for Vaccination site pain. On 26-Feb-2021, VACCINATION SITE PAIN (injection site muscular soreness for about a day and half) had resolved. At the time of the report, URINARY TRACT INFECTION (Developing a UTI), ASTHENIA (feeling tired and weakened), DIZZINESS (woozy and queasy), NAUSEA (woozy and queasy) and FATIGUE (feeling tired and weakened) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Erythema, Joint swelling, Pain
Clinical narrative: Excruciating pain; Swollen ankle; Red spot on the arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red spot on the arm), PAIN (Excruciating pain) and JOINT SWELLING (Swollen ankle) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroiditis. Concomitant products included COLECALCIFEROL (VITAMINS D3), MAGNESIUM CITRATE and PROBIOTICS NOS for an unknown indication.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced ERYTHEMA (Red spot on the arm). On 22-Jan-2021, the patient experienced PAIN (Excruciating pain) and JOINT SWELLING (Swollen ankle). The patient was treated with COLCHICINE on 22-Jan-2021 for Gout, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, ERYTHEMA (Red spot on the arm) and PAIN (Excruciating pain) outcome was unknown and JOINT SWELLING (Swollen ankle) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Blood test: inconclusive (Inconclusive) No gout marker found in blood.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant products includes Thyroid medication and Drop digestion Iberogast.   This case was linked to MOD-2021-024898 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Follow up received on 24-JUN-2021 contains non significant information. Patient's contact information was updated.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Maternal exposure during pregnancy, Myalgia
Clinical narrative: body aches; chills; pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnant), MYALGIA (body aches) and CHILLS (chills) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20-2A and 0-30L20A) for COVID-19 vaccination.     Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 28-Nov-2020 and the estimated date of delivery was 04-Sep-2021. On 24-Dec-2020, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnant). On 22-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (body aches) and CHILLS (chills). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  third week of the pregnancy.  The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 24-Dec-2020, MATERNAL EXPOSURE DURING PREGNANCY (pregnant) had resolved. At the time of the report, MYALGIA (body aches) and CHILLS (chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Chills, Cough, Diarrhoea, Dizziness
Clinical narrative: pain in the lungs; dry cough; dizziness; high frequency of bathroom use; unsteadiness; mucous; phlegm; arm feeling limp; sharp pain in the left arm/aching in the left arm; chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PULMONARY PAIN (pain in the lungs), COUGH (dry cough), DIZZINESS (dizziness), DIARRHOEA (high frequency of bathroom use) and BALANCE DISORDER (unsteadiness) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CALCIUM, VITAMIN D NOS and VITAMIN C [ASCORBIC ACID] for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PULMONARY PAIN (pain in the lungs), COUGH (dry cough), DIZZINESS (dizziness), DIARRHOEA (high frequency of bathroom use), BALANCE DISORDER (unsteadiness), SECRETION DISCHARGE (mucous), PRODUCTIVE COUGH (phlegm), MUSCULAR WEAKNESS (arm feeling limp), VACCINATION SITE PAIN (sharp pain in the left arm/aching in the left arm) and CHILLS (chills). At the time of the report, PULMONARY PAIN (pain in the lungs), COUGH (dry cough), DIZZINESS (dizziness), DIARRHOEA (high frequency of bathroom use), BALANCE DISORDER (unsteadiness), SECRETION DISCHARGE (mucous), PRODUCTIVE COUGH (phlegm), MUSCULAR WEAKNESS (arm feeling limp), VACCINATION SITE PAIN (sharp pain in the left arm/aching in the left arm) and CHILLS (chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Follow-up added on 15-Apr-2021 here attached the 1st doses Batch No and added the concomitant drug as Calcium, Vitamin D, Vitamin C and So many events was attached.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Productive cough, Pulmonary pain, Secretion discharge, Vaccination site pain
Clinical narrative: pain in the lungs; dry cough; dizziness; high frequency of bathroom use; unsteadiness; mucous; phlegm; arm feeling limp; sharp pain in the left arm/aching in the left arm; chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PULMONARY PAIN (pain in the lungs), COUGH (dry cough), DIZZINESS (dizziness), DIARRHOEA (high frequency of bathroom use) and BALANCE DISORDER (unsteadiness) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CALCIUM, VITAMIN D NOS and VITAMIN C [ASCORBIC ACID] for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PULMONARY PAIN (pain in the lungs), COUGH (dry cough), DIZZINESS (dizziness), DIARRHOEA (high frequency of bathroom use), BALANCE DISORDER (unsteadiness), SECRETION DISCHARGE (mucous), PRODUCTIVE COUGH (phlegm), MUSCULAR WEAKNESS (arm feeling limp), VACCINATION SITE PAIN (sharp pain in the left arm/aching in the left arm) and CHILLS (chills). At the time of the report, PULMONARY PAIN (pain in the lungs), COUGH (dry cough), DIZZINESS (dizziness), DIARRHOEA (high frequency of bathroom use), BALANCE DISORDER (unsteadiness), SECRETION DISCHARGE (mucous), PRODUCTIVE COUGH (phlegm), MUSCULAR WEAKNESS (arm feeling limp), VACCINATION SITE PAIN (sharp pain in the left arm/aching in the left arm) and CHILLS (chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Follow-up added on 15-Apr-2021 here attached the 1st doses Batch No and added the concomitant drug as Calcium, Vitamin D, Vitamin C and So many events was attached.